SAB Biotherapeutics, Inc. – NASDAQ:SABS
SAB Biotherapeutics stock price today
$2.02
-2.15
-51.67%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
SAB Biotherapeutics stock price monthly change
+39.80%
month
SAB Biotherapeutics stock price quarterly change
+39.80%
quarter
SAB Biotherapeutics stock price yearly change
+505.80%
year
SAB Biotherapeutics key metrics
Market Cap | 40.88M |
Enterprise value | 15.15M |
P/E | -0.84 |
EV/Sales | 0.18 |
EV/EBITDA | -0.61 |
Price/Sales | 0.21 |
Price/Book | 0.57 |
PEG ratio | N/A |
EPS | -6.73 |
Revenue | 2.60M |
EBITDA | -37.11M |
Income | -39.86M |
Revenue Q/Q | 62.54% |
Revenue Y/Y | -58.89% |
Profit margin | -33.5% |
Oper. margin | -40.85% |
Gross margin | 7.69% |
EBIT margin | -40.85% |
EBITDA margin | -1426.22% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSAB Biotherapeutics stock price history
SAB Biotherapeutics stock forecast
SAB Biotherapeutics financial statements
| Jun 2023 | 85.51K | -6.88M | -8046.13% |
|---|---|---|---|
| Sep 2023 | 1.26M | -5.10M | -402.59% |
| Dec 2023 | 305.01K | -22.85M | -7493.75% |
| Mar 2024 | 944.57K | -5.02M | -532.06% |
| Sep 2025 | 208.20K | -6.51M | -3131.36% |
|---|---|---|---|
| Oct 2025 | 208.20K | -7.30M | -3506.74% |
| Dec 2025 | 138.29K | -62.88M | -45472.9% |
| Dec 2025 | 138.29K | -7.39M | -5346.18% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 35442560 | 15.72M | 44.37% |
|---|---|---|---|
| Sep 2023 | 28336297 | 13.08M | 46.16% |
| Dec 2023 | 83941253 | 26.64M | 31.74% |
| Mar 2024 | 71371082 | 18.54M | 25.99% |
| Jun 2023 | -4.89M | -22.68K | -363.78K |
|---|---|---|---|
| Sep 2023 | -5.16M | -40.85K | -140.30K |
| Dec 2023 | -13.44M | -67.86K | 67.63M |
| Mar 2024 | -10.91M | -31.35M | -227.02K |
SAB Biotherapeutics alternative data
| Aug 2023 | 56 |
|---|---|
| Sep 2023 | 56 |
| Oct 2023 | 56 |
| Nov 2023 | 56 |
| Dec 2023 | 56 |
| Jan 2024 | 56 |
| Feb 2024 | 56 |
| Mar 2024 | 56 |
| Apr 2024 | 56 |
| May 2024 | 57 |
| Jun 2024 | 57 |
| Jul 2024 | 57 |
SAB Biotherapeutics other data
4.49%
-5.02%
of SABS is owned by hedge funds
21
-15
1.93M
-2.16M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2023 | 16000 | 0 |
| Dec 2023 | 1740 | 0 |
-
What's the price of SAB Biotherapeutics stock today?
One share of SAB Biotherapeutics stock can currently be purchased for approximately $2.02.
-
When is SAB Biotherapeutics's next earnings date?
Unfortunately, SAB Biotherapeutics's (SABS) next earnings date is currently unknown.
-
Does SAB Biotherapeutics pay dividends?
No, SAB Biotherapeutics does not pay dividends.
-
How much money does SAB Biotherapeutics make?
SAB Biotherapeutics has a market capitalization of 40.88M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 90.63% to 2.24M US dollars.
-
What is SAB Biotherapeutics's stock symbol?
SAB Biotherapeutics, Inc. is traded on the NASDAQ under the ticker symbol "SABS".
-
What is SAB Biotherapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of SAB Biotherapeutics?
Shares of SAB Biotherapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does SAB Biotherapeutics have?
As Jul 2024, SAB Biotherapeutics employs 57 workers, which is 2% more then previous quarter.
-
When SAB Biotherapeutics went public?
SAB Biotherapeutics, Inc. is publicly traded company for more then 4 years since IPO on 9 Feb 2021.
-
What is SAB Biotherapeutics's official website?
The official website for SAB Biotherapeutics is sabbiotherapeutics.com.
-
Where are SAB Biotherapeutics's headquarters?
SAB Biotherapeutics is headquartered at 2100 East 54th Street North, Sioux Falls, SD.
-
How can i contact SAB Biotherapeutics?
SAB Biotherapeutics's mailing address is 2100 East 54th Street North, Sioux Falls, SD and company can be reached via phone at +60 5 679 6980.
SAB Biotherapeutics company profile:
SAB Biotherapeutics, Inc.
sabbiotherapeutics.comExchange:
NASDAQ
Full time employees:
57
Industry:
Biotechnology
Sector:
Healthcare
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ transplantation, and cancer. The company uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors. Its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development to treat or prevent severe influenza. The company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. The company was founded in 2014 and is based in Sioux Falls, South Dakota.
2100 East 54th Street North
Sioux Falls, SD 57104
Sioux Falls, SD 57104
CIK: 0001833214
ISIN: US78397T2024
CUSIP: 78397T103
